Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | FURIN | P09958 | 2/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL943014 | 0.98 | PARP10 (0.46) | PARP10ALDH1A1TSHRSMN1; SMN2EPHX2 | |
| SCHEMBL18058688 | 0.85 | SMN1; SMN2 (0.54) | PARP10ALDH1A1TSHRSMN1; SMN2EPHX2 | |
| SCHEMBL2242868 | 0.84 | PARP10 (0.55) | PARP10ALDH1A1TSHREPHX2HPGD | |
| SCHEMBL20443245 | 0.80 | MAOB (0.47) | PARP10ALDH1A1TSHRSMN1; SMN2EPHX2 | |
| SCHEMBL16195543 | 0.80 | SMN1; SMN2 (0.67) | PARP10ALDH1A1TSHRSMN1; SMN2HPGD | |
| SCHEMBL8438185 | 0.78 | PARP10 (0.47) | PARP10ALDH1A1TSHRSMN1; SMN2HPGD | |
| SCHEMBL28410040 | 0.77 | SMN1; SMN2 (0.59) | PARP10ALDH1A1TSHRSMN1; SMN2EPHX2 | |
| SCHEMBL747626 | 0.77 | PARP10 (0.55) | PARP10ALDH1A1TSHREPHX2HPGD | |
| SCHEMBL9304772 | 0.76 | SLC6A4 (0.58) | PARP10ALDH1A1TSHRSMN1; SMN2EPHX2 | |
| SCHEMBL1837838 | 0.76 | PARP10 (0.53) | PARP10ALDH1A1TSHRSMN1; SMN2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110306798-A1 | Methods for Producing Arylsulfur Pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2011-12-15 | — | — | US | disclosed |
| WO-2010014665-A1 | METHODS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM&T RESEARCH, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306798-A1 | Methods for Producing Arylsulfur Pentafluorides | PFAS, ARSA, HDHD5 | PARP10 4496/4885ALDH1A1 992/4885TSHR 93/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.